Case Report: Alopecia Areata Universalis Successfully Treated with Baricitinib
TLDR Baricitinib successfully treated severe hair loss.
Alopecia areata is an autoimmune dermatological condition causing non-scarring hair loss, affecting about 2% of the population. It is multifactorial, with genetic predisposition and triggers like stress and other immune-mediated diseases. Traditional treatments are often ineffective long-term and have high adverse risks. This case report details a successful treatment of alopecia areata universalis with Baricitinib, a selective Janus kinase inhibitor, highlighting its potential as a promising long-term therapy.
